Zachary Zimmerman, Forge Therapeutics CEO
January 3, 2023 07:49 AM ESTUpdated 08:38 AM
Deals

Forge spin­off Black­smith Med­i­cines merges back in­to com­pa­ny two years af­ter launch, but de­tails are slim

Katherine Lewin

News Reporter

Black­smith Med­i­cines and Forge Ther­a­peu­tics an­nounced Mon­day that the com­pa­nies are merg­ing on­ly a year af­ter Black­smith launched as a spin­out …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times